Quince Therapeutics, Inc. (QNCX)

Quince Therapeutics Statistics

Total Valuation

QNCX has a market cap or net worth of $199.90 million. The enterprise value is $191.60 million.

Market Cap	199.90M
Enterprise Value	191.60M

Important Dates

The last earnings date was Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

QNCX has 55.68 million shares outstanding. The number of shares has increased by 10.61% in one year.

Current Share Class	55.68M
Shares Outstanding	55.68M
Shares Change (YoY)	+10.61%
Shares Change (QoQ)	+15.56%
Owned by Insiders (%)	10.66%
Owned by Institutions (%)	17.48%
Float	46.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	181.14
P/TBV Ratio	335.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 16.99.

Current Ratio	1.12
Quick Ratio	1.05
Debt / Equity	16.99
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-45.74

Financial Efficiency

Return on equity (ROE) is -247.78% and return on invested capital (ROIC) is -65.78%.

Return on Equity (ROE)	-247.78%
Return on Assets (ROA)	-22.10%
Return on Invested Capital (ROIC)	-65.78%
Return on Capital Employed (ROCE)	-49.85%
Revenue Per Employee	n/a
Profits Per Employee	-$1.58M
Employee Count	36
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, QNCX has paid $75,000 in taxes.

Income Tax	75,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +66.20% in the last 52 weeks. The beta is 1.04, so QNCX's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	+66.20%
50-Day Moving Average	2.01
200-Day Moving Average	1.55
Relative Strength Index (RSI)	77.28
Average Volume (20 Days)	1,026,783

Short Selling Information

The latest short interest is 1.37 million, so 2.45% of the outstanding shares have been sold short.

Short Interest	1.37M
Short Previous Month	1.31M
Short % of Shares Out	2.45%
Short % of Float	2.94%
Short Ratio (days to cover)	4.10

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-41.80M
Pretax Income	-56.90M
Net Income	-56.98M
EBITDA	-41.68M
EBIT	-41.80M
Earnings Per Share (EPS)	-$1.21

Balance Sheet

The company has $26.29 million in cash and $17.99 million in debt, giving a net cash position of $8.30 million or $0.15 per share.

Cash & Cash Equivalents	26.29M
Total Debt	17.99M
Net Cash	8.30M
Net Cash Per Share	$0.15
Equity (Book Value)	1.06M
Book Value Per Share	0.02
Working Capital	3.16M

Cash Flow

In the last 12 months, operating cash flow was -$38.50 million and capital expenditures -$481,000, giving a free cash flow of -$38.98 million.

Operating Cash Flow	-38.50M
Capital Expenditures	-481,000
Free Cash Flow	-38.98M
FCF Per Share	-$0.70

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

QNCX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.61%
Shareholder Yield	-10.61%
Earnings Yield	-28.50%
FCF Yield	-19.50%

Analyst Forecast

The average price target for QNCX is $7.75, which is 115.88% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.75
Price Target Difference	115.88%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1